A multicenter, randomized, double-blind, placebocontrolled phase III study to evaluate the efficacy, safety and tolerability of Serelaxin when added to standard therapy in acute heart failure patients The purpose of this study is to evaluate the eff...

Clinical Studies - Jun 20, 2014 - Mar 22, 2017

Completed

Project leader: Maeder Micha
Members: Gall Christian, Gemperle Michaela

Evidence based treatment in heart failure (EVITA-HF) mit Teilprojekt Registry analysis of iron deficiency in heart failure (RAID-HF).

Clinical Studies - May 14, 2012 - Dec 31, 2016

Completed

Project leader: Rickli Hans
Members: Maeder Micha, Gall Christian, Gemperle Michaela